Panel Vote Underscores Clinical Benefits of Biventricular Pacing for Better Patient Outcomes and Improved Quality of Life MINNEAPOLIS - The U.S. Food and Drug Administration's (FDA) Circulatory ...
A joint task force from the American College of Cardiology and American Heart Association published a set of guidelines in 1998, [33] based on currently available data to establish a uniform set of ...
MINNEAPOLIS - Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results